FRMPD3 Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
This kinase inhibitor targets a broad spectrum of protein kinases, leading to downstream inhibition of various signaling pathways. In the context of FRMPD3, staurosporine may disrupt interactions with kinases that modulate the cytoskeletal organization and cell adhesion, functions that FRMPD3 is implicated in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A phosphoinositide 3-kinase (PI3K) inhibitor that impairs the PI3K/AKT pathway. Since FRMPD3 has been linked to cell adhesion and PI3K signaling is crucial in cell survival and motility, inhibition of this pathway can indirectly affect FRMPD3's role in these processes. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $48.00 $122.00 $432.00 $812.00 | 4 | |
A potent inhibitor of the N-WASP, which is involved in actin polymerization. Since FRMPD3 is associated with the regulation of the actin cytoskeleton, the inhibition of N-WASP would likely disrupt the normal function of FRMPD3 in actin dynamics. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $71.00 $260.00 $485.00 $949.00 | ||
An inhibitor of non-muscle myosin II ATPase activity. This compound prevents proper myosin II function, which could interfere with FRMPD3's role in maintaining cytoskeletal integrity and cellular morphology. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An MEK inhibitor that interrupts the MAPK/ERK pathway. By inhibiting this pathway, PD 98059 could indirectly impact FRMPD3's function related to cell adhesion and motility that are regulated through MAPK/ERK signaling. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A selective inhibitor of the Rho-associated, coiled-coil containing protein kinase (ROCK). This kinase is intimately involved in actin cytoskeleton organization. Inhibition of ROCK might indirectly suppress FRMPD3's influence on cytoskeletal dynamics and cell shape. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $148.00 $597.00 | 75 | |
A Rac1 inhibitor that suppresses Rac1-dependent cell motility and cytoskeletal reorganization. Since FRMPD3 is involved in actin cytoskeleton organization, NSC 23766 could indirectly reduce FRMPD3's functional activity in these processes. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
An actin polymerization inhibitor that sequesters actin monomers and thus prevents filament formation. As FRMPD3 is associated with actin dynamics, the inhibition of actin polymerization by Latrunculin A would likely diminish FRMPD3's role in cytoskeletal organization. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
An inhibitor of myosin light chain kinase (MLCK), which is important in controlling actin-myosin contractility. FRMPD3, being involved in cytoskeletal modulation, might be functionally inhibited due to the disruption of actin-myosin dynamics by ML-7 hydrochloride. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $103.00 $293.00 $465.00 | 15 | |
A protein kinase C (PKC) inhibitor that influences a variety of cellular processes, including cytoskeletal organization. The inhibition of PKC activity by Gö 6983 could indirectly affect the functional role of FRMPD3 in these processes. | ||||||